The Solution
Harnessing the power of peer-reviewed published case reports.
Of all types of real-world evidence, case reports are particularly rich in information regarding:
The patient therapeutic journey
Causality of clinical events
Novel or rare clinical events
Detailed descriptions of clinical events
INTRODUCING...
The world’s first tool to systematically aggregate, filter, and synthesize real-world evidence from case reports regarding oncology therapeutic adverse events
OpenCase™ currently holds 100,000 oncology therapeutic adverse events and counting.
OpenCase™ captures data from a wide range of oncological conditions and geographic regions.
Hematologic Cancer | 15,000+ patients
lymphoma, myeloma, leukemia, and others
Solid Tumors | 30,000+ patients
lung, breast, colorectal, skin, bladder, pancreatic
Pediatric Cancers | 2,500+ patients
leukemia, neuroblastoma, rhabdomyosarcoma, and others
AND COMING SOON…
CNS Cancers | 20,000+ patients
brain and spine, gliomas and schwannomas, and others
